Relief Therapeutics Holding SA logo

Relief Therapeutics Holding SA

0001854078

MindMaze Therapeutics is a leader in developing innovative neurotherapeutic combinations, encompassing behavior, software, devices, and data. They offer a treatment ecosystem that redefines the future of brain repair and neurological recovery. Their platform integrates various therapies to improve patient outcomes.

85
Sehr Vertrauenswürdig
Vertrauensscore

Offizielles Register

Umsatzsteuer-ID
000000000
Adresse
AVENUE DE SECHERON 15, CH-1202 GENEVA, V8 NA
Branchencodes
Pharmaceutical Preparations, 2834

KI-Qualitätsanalyse

Branche
Biotechnology
SSL/HTTPS
Sicher
Professionelle E-Mail
Ja
Kontakt E-Mail
01info@mindmaze.com

Vertrauensscore-Details

Register verifiziert35/35
Qualitätsbewertung50/60
Nachrichtenstimmung0/5

Website-Highlights

Zuletzt aktualisiert: 1/2/2026

🌟 Ähnliche vertrauenswürdige Unternehmen

Context Therapeutics Inc.

Context Therapeutics Inc. logo
86/100 · Sehr Vertrauenswürdig

Context Therapeutics is dedicated to advancing the treatment of solid tumors through the development of next-generation T cell engaging (TCE) bispecific antibody therapies. Their innovative pipeline features clinical-stage bispecific therapeutics designed to harness the immune system for targeted cancer eradication. The company focuses on innovative immunotherapeutic solutions, transforming cancer care and improving outcomes for patients.

2001 MARKET STREET, USA
Profil ansehen

AGENUS INC

AGENUS INC logo
86/100 · Sehr Vertrauenswürdig

Agenus is a biotechnology company focused on developing and commercializing immuno-oncology therapies. Their key products include botensilimab and balstilimab, which are in clinical trials for various cancers. The company is positioned as an innovator in the development of next-generation immunotherapies.

3 FORBES ROAD, USA
Profil ansehen

Evaxion A/S

Evaxion A/S logo
77/100 · Vertrauenswürdig

Evaxion utilizes its AI-Immunology™ platform to challenge and improve standardized treatments. In oncology, they create personalized therapies, tailoring treatment to the individual. For infectious diseases, they design next-generation vaccines to address unmet medical needs. Their AI platform accelerates vaccine target discovery, design, and development.

DR NEERGAARDS VEJ 5F, USA
Profil ansehen